{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:03:16Z","timestamp":1793833396840,"version":"4.6.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.imbio.2010.09.014","type":"journal-article","created":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T05:01:38Z","timestamp":1285822898000},"page":"579-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["T lymphocyte proliferation is suppressed by the opioid growth factor ([Met5]-enkephalin)\u2013opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases"],"prefix":"10.1016","volume":"216","author":[{"given":"Ian S.","family":"Zagon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee N.","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Bonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2010.09.014_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.ne.07.030184.001255","article-title":"Endogenous opioids: biology and function","volume":"7","author":"Akil","year":"1984","journal-title":"Ann. Rev. Neurosci."},{"key":"10.1016\/j.imbio.2010.09.014_bib0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1067\/mva.2000.107763b","article-title":"Opioid growth factor modulates angiogenesis","volume":"32","author":"Blebea","year":"2000","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.imbio.2010.09.014_bib0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3181\/00379727-213-44056","article-title":"The relevance of opioids and opioid receptors on immumocompetence and immune homeostasis","volume":"213","author":"Carr","year":"1996","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.imbio.2010.09.014_bib0020","doi-asserted-by":"crossref","first-page":"R774","DOI":"10.1152\/ajpregu.00318.2010","article-title":"Internalization of the opioid growth factor. [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferation","volume":"299","author":"Cheng","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0025","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3181\/0901-RM-16","article-title":"Dependence on nuclear localization signals of the opioid growth factor receptor in the regulation of cell proliferation","volume":"234","author":"Cheng","year":"2009","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.imbio.2010.09.014_bib0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1091\/mbc.e08-07-0681","article-title":"The OGF\u2013OGFr axis utilizes the p16INK4a and p21WAF1\/CIP1 pathways to restrict normal cell proliferation","volume":"1","author":"Cheng","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.imbio.2010.09.014_bib0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-4598-7-5","article-title":"The OGF\u2013OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer","volume":"7","author":"Cheng","year":"2007","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.imbio.2010.09.014_bib0040","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1258\/ebm.2010.010139","article-title":"Regulation of cell proliferation by the opioid growth factor is dependent on karyopherin \u03b2 and Ran for nucleocytoplasmic trafficking","volume":"235","author":"Cheng","year":"2010","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.imbio.2010.09.014_bib0045","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.1158\/0008-5472.CAN-07-1922","article-title":"The OGF\u2013OGFr axis utilizes the p16 pathway to inhibit progression of human squamous cell carcinoma of the head and neck","volume":"67","author":"Cheng","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.imbio.2010.09.014_bib0050","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1006\/bbrc.1994.2071","article-title":"Delta opioid receptor gene expression in lymphocytes","volume":"202","author":"Chuang","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.imbio.2010.09.014_bib0055","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1006\/bbrc.1995.1597","article-title":"Expression of kappa opioid receptors in human and monkey lymphocytes","volume":"209","author":"Chuang","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.imbio.2010.09.014_bib0060","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0024-3205(96)00057-4","article-title":"Phosphorylation of enkephalins enhances their proteolytic stability","volume":"58","author":"Dass","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.imbio.2010.09.014_bib0065","doi-asserted-by":"crossref","first-page":"R1716","DOI":"10.1152\/ajpregu.00075.2009","article-title":"Cell proliferation of human ovarian cancer is regulated by the opioid growth factor\u2013opioid growth factor receptor axis","volume":"296","author":"Donahue","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0070","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1073\/pnas.79.13.4226","article-title":"\u03b2-endorphin enhances lymphocyte proliferative responses","volume":"79","author":"Gilman","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.imbio.2010.09.014_bib0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0162-3109(89)90004-0","article-title":"The opioid specificity of beta-endorphin enhancement of murine lymphocyte proliferation","volume":"7","author":"Gilmore","year":"1989","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.imbio.2010.09.014_bib0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0165-5728(90)90167-L","article-title":"\u03b2-endorphin stimulates rat T lymphocyte proliferation","volume":"29","author":"Hemmick","year":"1990","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0165-5728(90)90066-V","article-title":"\u03b2-Endorphin modulates T-cell intracellular calcium flux and c-myc expression via a potassium channel","volume":"27","author":"Hough","year":"1990","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0162-3109(90)90043-E","article-title":"Stimulation of human peripheral lymphocytes by methionine enkephalin and delta-selective opioid analogues","volume":"19","author":"Hucklebridge","year":"1990","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.imbio.2010.09.014_bib0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0889-1591(89)90019-6","article-title":"Methionine-enkephalin stimulates in vitro proliferation of human peripheral lymphocytes via delta-opioid receptors","volume":"3","author":"Hucklebridge","year":"1989","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.imbio.2010.09.014_bib0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3835(96)04119-5","article-title":"Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone","volume":"101","author":"Hytrek","year":"1996","journal-title":"Cancer Lett."},{"key":"10.1016\/j.imbio.2010.09.014_bib0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jneuroim.2007.06.013","article-title":"Opioid receptor blockade increases the number of lymphocytes without altering T cell response in draining lymph nodes in vivo","volume":"188","author":"Jaume","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-5728(97)00240-3","article-title":"Role of endogenous pro-enkephalin A-derived peptides in human T cell proliferation and monocyte IL-6 production","volume":"84","author":"Kamphuis","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(98)00079-X","article-title":"Immunologic action of [Met5]enkephalin fragments","volume":"347","author":"Kowalski","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0143-4179(98)90052-X","article-title":"Immunomodulatory action of class \u03bc-, \u03b4-, and \u03ba-opioid receptor agonists in mice","volume":"32","author":"Kowalski","year":"1998","journal-title":"Neuropeptides"},{"key":"10.1016\/j.imbio.2010.09.014_bib0125","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1172\/JCI115382","article-title":"Differential processing of proenkephalin-A by human peripheral blood monocytes and T lymphocytes","volume":"88","author":"Kuis","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2010.09.014_bib0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0889-1591(87)90010-9","article-title":"In vivo effects of \u03b2-endorphin on lymphocyte proliferation and interleukin 2 production","volume":"1","author":"Kusnecov","year":"1987","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.imbio.2010.09.014_bib0135","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0196-9781(89)90061-2","article-title":"Modulation of mitogen-induced spleen cell proliferation and the antibody-forming cell response by beta-endorphin in vivo","volume":"10","author":"Kusnecov","year":"1989","journal-title":"Peptides"},{"key":"10.1016\/j.imbio.2010.09.014_bib0140","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.4049\/jimmunol.154.10.5049","article-title":"Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation","volume":"154","author":"Linner","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0145","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI112501","article-title":"Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages","volume":"77","author":"Lolait","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2010.09.014_bib0150","doi-asserted-by":"crossref","first-page":"934","DOI":"10.4049\/jimmunol.136.3.934","article-title":"\u03b2-Endorphin augments the cytolytic activity and interferon production of natural killer cells","volume":"136","author":"Mandler","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0155","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/oxfordjournals.humrep.a136045","article-title":"Mitogen-induced lymphocyte proliferation and peripheral blood mononuclear cell \u03b2-endorphin concentrations in primary dysmenorrhea","volume":"10","author":"Marchini","year":"1995","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.imbio.2010.09.014_bib0160","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1749-6632.1987.tb35755.x","article-title":"Enkephalins and immunity. II. In vivo modulation of cell-mediated immunity","volume":"496","author":"Mari\u0107","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.imbio.2010.09.014_bib0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jnr.490180114","article-title":"Preproenkephalin mRNA in T-cells, macrophages, and mast cells","volume":"18","author":"Martin","year":"1987","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.imbio.2010.09.014_bib0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0376-8716(00)00181-2","article-title":"Opioids, opioid receptors, and the immune response","volume":"62","author":"McCarthy","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.imbio.2010.09.014_bib0175","first-page":"809","article-title":"Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of paclitaxel and opioid growth factor","volume":"26","author":"McLaughlin","year":"2005","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0180","first-page":"751","article-title":"Prevention and delay in progression of human squamous cell carcinoma of the head and neck in nude mice by stable overexpression of the opioid growth factor receptor","volume":"33","author":"McLaughlin","year":"2008","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0185","unstructured":"McLaughlin, P.J., Rogosnitzky, M., Zagon, I.S., in press. Inhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors. Exp. Biol. Med."},{"key":"10.1016\/j.imbio.2010.09.014_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0192-0561(98)00068-X","article-title":"Imiquimod applied topically: a novel immune response modifier and new class of drug","volume":"21","author":"Miller","year":"1999","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0195","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0090-1229(89)90152-9","article-title":"Immunoregulatory effects of alpha-endorphin, beta-endorphin, methionine-enkephalin, and adrenocorticotropic hormone on anti-tetanus toxoid antibody synthesis by human lymphocytes","volume":"52","author":"Munn","year":"1989","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0200","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jneuroim.2005.09.012","article-title":"Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation","volume":"171","author":"Nair","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1054\/npep.1999.0008","article-title":"Dynorphin A enhances mitogen-induced proliferative response and interleukin-2 production of rat splenocytes","volume":"33","author":"Ni","year":"1999","journal-title":"Neuropeptides"},{"key":"10.1016\/j.imbio.2010.09.014_bib0210","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/295202a0","article-title":"Cloning and sequencing analysis of cDNA for bovine adrenal preproenkephalin","volume":"295","author":"Noda","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2010.09.014_bib0215","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1349-7006.2008.01073.x","article-title":"Methionine-enkephalin secreted by human colorectal cancer cells suppresses T lymphocytes","volume":"100","author":"Ohmori","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.imbio.2010.09.014_bib0220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0143-4179(98)90028-2","article-title":"The C-terminal tetrapeptide of \u03b2-endorphin (MPF) enhances lymphocyte proliferative responses","volume":"32","author":"Owen","year":"1998","journal-title":"Neuropeptides"},{"key":"10.1016\/j.imbio.2010.09.014_bib0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0165-5728(97)00222-1","article-title":"The opioid-cytokine connection","volume":"83","author":"Peterson","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0230","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0192-0561(83)90020-6","article-title":"Enkephalins as immunomodulators","volume":"5","author":"Plotnikoff","year":"1983","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0235","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0014-4886(86)90086-5","article-title":"The in vitro effects of endogenous opiates on natural killer cells, antigen-specific cytolytic T cells, and T-cell subsets","volume":"92","author":"Prete","year":"1986","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0240","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1096\/fasebj.3.12.2529160","article-title":"Nonopiate active proenkephalin-derived peptides are secreted by T helper cells","volume":"3","author":"Roth","year":"1989","journal-title":"FASEB J."},{"key":"10.1016\/j.imbio.2010.09.014_bib0245","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0145-305X(00)00047-1","article-title":"Involvement of pro-enkephain-derived peptides in immunity","volume":"25","author":"Salzet","year":"2001","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0250","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/0006-291X(91)91655-V","article-title":"N-acetyl-\u03b2-endorphin1\u201331 antagonizes the suppressive effect of \u03b2-endorphin1\u201331 on murine splenocyte proliferation via a naloxone-resistant receptor","volume":"175","author":"Shahabi","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.imbio.2010.09.014_bib0255","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0022-3565(25)09571-0","article-title":"Antiproliferative effects of delta opioids on highly purified CD4+ and CD8+ murine T cells","volume":"273","author":"Shahabi","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.imbio.2010.09.014_bib0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2003.10.005","article-title":"Opioid receptor expression and function","volume":"147","author":"Sharp","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0265","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-5728(97)00220-8","article-title":"Evidence for opioid receptors on cells involved in host defense and the immune system","volume":"83","author":"Sharp","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0270","doi-asserted-by":"crossref","first-page":"7530","DOI":"10.1073\/pnas.78.12.7530","article-title":"Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon","volume":"78","author":"Smith","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.imbio.2010.09.014_bib0275","first-page":"1","article-title":"Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancer","volume":"2","author":"Smith","year":"2010","journal-title":"Open Access J. Clin. Trials"},{"key":"10.1016\/j.imbio.2010.09.014_bib0280","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00001813-200403000-00003","article-title":"Treatment of advanced pancreatic cancer with opioid growth factor: Phase I","volume":"15","author":"Smith","year":"2004","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.imbio.2010.09.014_bib0285","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1572-0241.2007.01045.x","article-title":"Low-dose naltrexone therapy improves active Crohn's disease","volume":"102","author":"Smith","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0290","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1124\/pr.56.3.2","article-title":"Opioids as modulators of cell death and survival \u2013 unraveling mechanisms and revealing new indications","volume":"56","author":"Tegeder","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.imbio.2010.09.014_bib0295","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1365-4362.2002.01597.x","article-title":"Imiquimod: an international update on therapeutic uses in dermatology","volume":"41","author":"Tyring","year":"2002","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0300","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1158\/1078-0432.CCR-04-0193","article-title":"Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-\u03b1","volume":"10","author":"Urosevic","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.imbio.2010.09.014_bib0305","first-page":"18","article-title":"Identification of two moieties of \u03b2-endorphin with opposing effects on T-cell proliferation","volume":"79","author":"van den Bergh","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.imbio.2010.09.014_bib0310","first-page":"537","article-title":"Two opposing modes of action of \u03b2-endorphin on lymphocyte function","volume":"72","author":"van den Bergh","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.imbio.2010.09.014_bib0315","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2184.2000.00161.x","article-title":"The opioid growth factor, [Met5]-enkephalin, inhibits DNA synthesis during recornification of mouse tail skin","volume":"33","author":"Wilson","year":"2000","journal-title":"Cell Prolif."},{"key":"10.1016\/j.imbio.2010.09.014_bib0320","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0143-4179(85)90031-9","article-title":"Enkephalins and endorphins: activation molecules for the immune system and natural killer activity?","volume":"5","author":"Wybran","year":"1985","journal-title":"Neuropeptides"},{"key":"10.1016\/j.imbio.2010.09.014_bib0325","doi-asserted-by":"crossref","first-page":"R1154","DOI":"10.1152\/ajpregu.00414.2009","article-title":"Opioid growth factor\u2013opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers","volume":"297","author":"Zagon","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0330","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3181\/0802-RM-58","article-title":"Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function","volume":"8","author":"Zagon","year":"2008","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.imbio.2010.09.014_bib0335","first-page":"317","article-title":"Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor","volume":"33","author":"Zagon","year":"2008","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0340","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.npep.2005.07.001","article-title":"Opioid growth factor, opioids, and differentiation of human cancer cells","volume":"39","author":"Zagon","year":"2005","journal-title":"Neuropeptides"},{"key":"10.1016\/j.imbio.2010.09.014_bib0345","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0143-4179(03)00007-6","article-title":"Opioids and the apoptotic pathway in human cancer cells","volume":"37","author":"Zagon","year":"2003","journal-title":"Neuropeptides"},{"key":"10.1016\/j.imbio.2010.09.014_bib0350","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0006-8993(93)90669-E","article-title":"Production and characterization of polyclonal and monoclonal antibodies to zeta (\u03b6) opioid receptor","volume":"630","author":"Zagon","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.imbio.2010.09.014_bib0355","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainres.2009.11.026","article-title":"Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis","volume":"1310","author":"Zagon","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.imbio.2010.09.014_bib0360","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3181\/0906-RM-189","article-title":"Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis","volume":"234","author":"Zagon","year":"2009","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.imbio.2010.09.014_bib0365","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ar.a.20161","article-title":"Nucleocytoplasmic distribution of opioid growth factor (OGF) and its receptor (OGFr) in tongue epithelium","volume":"282","author":"Zagon","year":"2005","journal-title":"Anat. Rec. A, Discov. Mol. Cell. Evol. Biol."},{"key":"10.1016\/j.imbio.2010.09.014_bib0370","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0006-8993(97)00238-2","article-title":"Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor","volume":"759","author":"Zagon","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.imbio.2010.09.014_bib0375","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0006-8993(98)00610-6","article-title":"Re-epithelization of the rabbit cornea is regulated by opioid growth factor","volume":"803","author":"Zagon","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.imbio.2010.09.014_bib0380","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/01.ico.0000153561.89902.57","article-title":"Particle-mediated gene transfer of OGFr cDNA regulates cell proliferation of the corneal epithelium","volume":"24","author":"Zagon","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.imbio.2010.09.014_bib0385","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0165-0173(01)00160-6","article-title":"The biology of the opioid growth factor receptor (OGFr)","volume":"38","author":"Zagon","year":"2002","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.imbio.2010.09.014_bib0390","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00917896","article-title":"Methionine-enkephalin as immunomodulator therapy in human immunodeficiency virus infections: clinical and immunological effects","volume":"8","author":"Zunich","year":"1988","journal-title":"J. Clin. Immunol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298510001841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298510001841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:26:59Z","timestamp":1759249619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298510001841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0171298510001841"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2010.09.014","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T lymphocyte proliferation is suppressed by the opioid growth factor ([Met5]-enkephalin)\u2013opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2010.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}